Abstract:Protein translation is a tightly regulated cellular process that is essential for gene expression and protein synthesis. The deregulation of this process is increasingly recognized as a critical factor in the pathogenesis of various human diseases. In this review, we discuss how deregulated translation can lead to aberrant protein synthesis, altered cellular functions, and disease progression. We explore the key mechanisms contributing to the deregulation of protein translation, including functional alterations in translation factors, tRNA, mRNA, and ribosome function. Deregulated translation leads to abnormal protein expression, disrupted cellular signaling, and perturbed cellular functions- all of which contribute to disease pathogenesis. The development of ribosome profiling techniques along with mass spectrometry-based proteomics, mRNA sequencing and single-cell approaches have opened new avenues for detecting diseases related to translation errors. Importantly, we highlight recent advances in therapies targeting translation-related disorders and their potential applications in neurodegenerative diseases, cancer, infectious diseases, and cardiovascular diseases. Moreover, the growing interest lies in targeted therapies aimed at restoring precise control over translation in diseased cells is discussed. In conclusion, this comprehensive review underscores the critical role of protein translation in disease and its potential as a therapeutic target. Advancements in understanding the molecular mechanisms of protein translation deregulation, coupled with the development of targeted therapies, offer promising avenues for improving disease outcomes in various human diseases. Additionally, it will unlock doors to the possibility of precision medicine by offering personalized therapies and a deeper understanding of the molecular underpinnings of diseases in the future.

The Regulation of Protein Translation and Its Implications for Cancer

Translational Regulation by eIFs and RNA Modifications in Cancer

Eukaryotic translation initiation factors and cancer.

Non-canonical translation in cancer: significance and therapeutic potential of non-canonical ORFs, m6A-modification, and circular RNAs

Targeting translation regulators improves cancer therapy

Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.

The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications

Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies

Translation of noncoding RNAs and cancer

Role of Main RNA Modifications in Cancer: N6-methyladenosine, 5-Methylcytosine, and Pseudouridine

The plasticity of mRNA translation during cancer progression and therapy resistance

Protein translation: biological processes and therapeutic strategies for human diseases

Critical Roles of METTL3 in Translation Regulation of Cancer

Global Analysis of Trna and Translation Factor Expression Reveals a Dynamic Landscape of Translational Regulation in Human Cancers.

The Emerging Role of Major Regulatory RNAs in Cancer Control

Translation Factors as Promising Targets

Targeting Translation of mRNA as a Therapeutic Strategy in Cancer

Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies

The Role of Mrna Translational Control in Tumor Immune Escape and Immunotherapy Resistance

The Dysregulation of Trnas and Trna Derivatives in Cancer